Selected research
Market Structure
Global Anti-Fungal Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Anti-Fungal Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Anti-Fungal Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anti-Fungal Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-Fungal Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Anti-Fungal Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anti-Fungal Agents include Novartis, Merck, Pfizer, GlaxoSmithKline, Bayer, Valeant Pharmaceuticals International, Sanofi-Aventis, Enzon Pharmaceutical and Basilea Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Anti-Fungal Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anti-Fungal Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anti-Fungal Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Fungal Agents market size, projected growth trends, production technologies, key applications, and end-use industries.
Anti-Fungal Agents Segment by Company
Novartis
Merck
Pfizer
GlaxoSmithKline
Bayer
Valeant Pharmaceuticals International
Sanofi-Aventis
Enzon Pharmaceutical
Basilea Pharmaceutical
Astellas Pharma
Agilent Technologies
Abbot
Anti-Fungal Agents Segment by Type
Azoles
Polyenes
5-fluorocytosine
Other
Anti-Fungal Agents Segment by Application
Hospital
Clinic
Other
Anti-Fungal Agents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Fungal Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Fungal Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Fungal Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anti-Fungal Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Fungal Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Fungal Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Anti-Fungal Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Azoles
- Polyenes
- 5-fluorocytosine
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Novartis
- Merck
- Pfizer
- GlaxoSmithKline
- Bayer
- Valeant Pharmaceuticals International
- Sanofi-Aventis
- Enzon Pharmaceutical
- Basilea Pharmaceutical
- Astellas Pharma
- Agilent Technologies
- Abbot
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Anti-Fungal Agents Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Anti-Fungal Agents Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Anti-Fungal Agents Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Anti-Fungal Agents Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Anti-Fungal Agents Market Dynamics
- 2.1 Anti-Fungal Agents Industry Trends
- 2.2 Anti-Fungal Agents Industry Drivers
- 2.3 Anti-Fungal Agents Industry Opportunities and Challenges
- 2.4 Anti-Fungal Agents Industry Restraints
3 Anti-Fungal Agents Market by Manufacturers
- 3.1 Global Anti-Fungal Agents Revenue by Manufacturers (2021-2026)
- 3.2 Global Anti-Fungal Agents Sales by Manufacturers (2021-2026)
- 3.3 Global Anti-Fungal Agents Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Anti-Fungal Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Anti-Fungal Agents Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Anti-Fungal Agents Manufacturers, Product Type & Application
- 3.7 Global Anti-Fungal Agents Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Anti-Fungal Agents Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Anti-Fungal Agents Players Market Share by Revenue in 2025
- 3.8.3 2025 Anti-Fungal Agents Tier 1, Tier 2, and Tier 3
4 Anti-Fungal Agents Market by Type
- 4.1 Anti-Fungal Agents Type Introduction
- 4.1.1 Azoles
- 4.1.2 Polyenes
- 4.1.3 5-fluorocytosine
- 4.1.4 Other
- 4.2 Global Anti-Fungal Agents Sales by Type
- 4.2.1 Global Anti-Fungal Agents Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Anti-Fungal Agents Sales by Type (2021-2032)
- 4.2.3 Global Anti-Fungal Agents Sales Market Share by Type (2021-2032)
- 4.3 Global Anti-Fungal Agents Revenue by Type
- 4.3.1 Global Anti-Fungal Agents Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Anti-Fungal Agents Revenue by Type (2021-2032)
- 4.3.3 Global Anti-Fungal Agents Revenue Market Share by Type (2021-2032)
5 Anti-Fungal Agents Market by Application
- 5.1 Anti-Fungal Agents Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Anti-Fungal Agents Sales by Application
- 5.2.1 Global Anti-Fungal Agents Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Anti-Fungal Agents Sales by Application (2021-2032)
- 5.2.3 Global Anti-Fungal Agents Sales Market Share by Application (2021-2032)
- 5.3 Global Anti-Fungal Agents Revenue by Application
- 5.3.1 Global Anti-Fungal Agents Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Anti-Fungal Agents Revenue by Application (2021-2032)
- 5.3.3 Global Anti-Fungal Agents Revenue Market Share by Application (2021-2032)
6 Global Anti-Fungal Agents Sales by Region
- 6.1 Global Anti-Fungal Agents Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Anti-Fungal Agents Sales by Region (2021-2032)
- 6.2.1 Global Anti-Fungal Agents Sales by Region (2021-2026)
- 6.2.2 Global Anti-Fungal Agents Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Anti-Fungal Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Anti-Fungal Agents Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Anti-Fungal Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Anti-Fungal Agents Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Anti-Fungal Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Anti-Fungal Agents Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Anti-Fungal Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Anti-Fungal Agents Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Anti-Fungal Agents Revenue by Region
- 7.1 Global Anti-Fungal Agents Revenue by Region
- 7.1.1 Global Anti-Fungal Agents Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Anti-Fungal Agents Revenue by Region (2021-2026)
- 7.1.3 Global Anti-Fungal Agents Revenue by Region (2027-2032)
- 7.1.4 Global Anti-Fungal Agents Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Anti-Fungal Agents Revenue (2021-2032)
- 7.2.2 North America Anti-Fungal Agents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Anti-Fungal Agents Revenue (2021-2032)
- 7.3.2 Europe Anti-Fungal Agents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Anti-Fungal Agents Revenue (2021-2032)
- 7.4.2 Asia-Pacific Anti-Fungal Agents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Anti-Fungal Agents Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Anti-Fungal Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Novartis
- 8.1.1 Novartis Company Information
- 8.1.2 Novartis Business Overview
- 8.1.3 Novartis Anti-Fungal Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Novartis Anti-Fungal Agents Product Portfolio
- 8.1.5 Novartis Recent Developments
- 8.2 Merck
- 8.2.1 Merck Company Information
- 8.2.2 Merck Business Overview
- 8.2.3 Merck Anti-Fungal Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Merck Anti-Fungal Agents Product Portfolio
- 8.2.5 Merck Recent Developments
- 8.3 Pfizer
- 8.3.1 Pfizer Company Information
- 8.3.2 Pfizer Business Overview
- 8.3.3 Pfizer Anti-Fungal Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer Anti-Fungal Agents Product Portfolio
- 8.3.5 Pfizer Recent Developments
- 8.4 GlaxoSmithKline
- 8.4.1 GlaxoSmithKline Company Information
- 8.4.2 GlaxoSmithKline Business Overview
- 8.4.3 GlaxoSmithKline Anti-Fungal Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 GlaxoSmithKline Anti-Fungal Agents Product Portfolio
- 8.4.5 GlaxoSmithKline Recent Developments
- 8.5 Bayer
- 8.5.1 Bayer Company Information
- 8.5.2 Bayer Business Overview
- 8.5.3 Bayer Anti-Fungal Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Bayer Anti-Fungal Agents Product Portfolio
- 8.5.5 Bayer Recent Developments
- 8.6 Valeant Pharmaceuticals International
- 8.6.1 Valeant Pharmaceuticals International Company Information
- 8.6.2 Valeant Pharmaceuticals International Business Overview
- 8.6.3 Valeant Pharmaceuticals International Anti-Fungal Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Valeant Pharmaceuticals International Anti-Fungal Agents Product Portfolio
- 8.6.5 Valeant Pharmaceuticals International Recent Developments
- 8.7 Sanofi-Aventis
- 8.7.1 Sanofi-Aventis Company Information
- 8.7.2 Sanofi-Aventis Business Overview
- 8.7.3 Sanofi-Aventis Anti-Fungal Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Sanofi-Aventis Anti-Fungal Agents Product Portfolio
- 8.7.5 Sanofi-Aventis Recent Developments
- 8.8 Enzon Pharmaceutical
- 8.8.1 Enzon Pharmaceutical Company Information
- 8.8.2 Enzon Pharmaceutical Business Overview
- 8.8.3 Enzon Pharmaceutical Anti-Fungal Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Enzon Pharmaceutical Anti-Fungal Agents Product Portfolio
- 8.8.5 Enzon Pharmaceutical Recent Developments
- 8.9 Basilea Pharmaceutical
- 8.9.1 Basilea Pharmaceutical Company Information
- 8.9.2 Basilea Pharmaceutical Business Overview
- 8.9.3 Basilea Pharmaceutical Anti-Fungal Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Basilea Pharmaceutical Anti-Fungal Agents Product Portfolio
- 8.9.5 Basilea Pharmaceutical Recent Developments
- 8.10 Astellas Pharma
- 8.10.1 Astellas Pharma Company Information
- 8.10.2 Astellas Pharma Business Overview
- 8.10.3 Astellas Pharma Anti-Fungal Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Astellas Pharma Anti-Fungal Agents Product Portfolio
- 8.10.5 Astellas Pharma Recent Developments
- 8.11 Agilent Technologies
- 8.11.1 Agilent Technologies Company Information
- 8.11.2 Agilent Technologies Business Overview
- 8.11.3 Agilent Technologies Anti-Fungal Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Agilent Technologies Anti-Fungal Agents Product Portfolio
- 8.11.5 Agilent Technologies Recent Developments
- 8.12 Abbot
- 8.12.1 Abbot Company Information
- 8.12.2 Abbot Business Overview
- 8.12.3 Abbot Anti-Fungal Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Abbot Anti-Fungal Agents Product Portfolio
- 8.12.5 Abbot Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Anti-Fungal Agents Value Chain Analysis
- 9.1.1 Anti-Fungal Agents Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Anti-Fungal Agents Production Mode & Process
- 9.2 Anti-Fungal Agents Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Anti-Fungal Agents Distributors
- 9.2.3 Anti-Fungal Agents Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst